Pooled across 34 studies data from 4.5+ million women showed that MHT use increased breast cancer odds by 15% versus non-use, but regimen-specific effects dominated the aggregate estimate.

Although menopause is not a new phenomenon by any means, the past few years of what some have called the “menopause moment” have brought it to the forefront of national conversation. One form of ...

In the article that accompanies this editorial, Dumas et al 12 modeled the potential improvements in 5-year disease-free survival (DFS) from hormone receptor–positive early-stage breast cancer if ...